Keyphrases
Cardiometabolic Risk
9%
Diabetes
9%
Diabetes Risk
9%
Early Biomarker
9%
Free Women
9%
Freeman
9%
Generalized Linear Model
9%
Glucose Intolerance
100%
Glucose-insulin System
100%
Gut Microbiota
9%
Hemoglobin A1c (HbA1c)
27%
High Performance Liquid Chromatography-tandem Mass Spectrometry (HPLC-MS/MS)
9%
Homeostasis Model Assessment of Insulin Resistance (HOMA-IR)
27%
Impaired Glucose Regulation
100%
Insulin
9%
Insulin Resistance
100%
Longitudinal Cohort Study
9%
Multivariable
18%
Oral Infection
100%
Overnight Fast
9%
Pre-diabetes (pre-DM)
27%
Prevalence Ratio
9%
Relative Risk Model
9%
Resistance Studies
100%
Trimethylamine N-oxide
100%
Medicine and Dentistry
Biological Marker
27%
Cardiometabolic Risk
9%
Cohort Analysis
9%
Diabetes
18%
Glucose Intolerance
100%
Gut Microbiota
9%
Hemoglobin A1c
18%
Homeostatic Model Assessment
27%
Impaired Glucose Tolerance
27%
Insulin Resistance
100%
Liquid Chromatography-Mass Spectrometry
9%
Mouth Infection
100%
Prevalence
18%
Trimethylamine
100%
Ultra Performance Liquid Chromatography
9%
Agricultural and Biological Sciences
Biological Marker
27%
Blood Plasma
100%
Impaired Glucose Tolerance
27%
Insulin Resistance
100%
Intestine Flora
9%
Linear Models
9%
Liquid Chromatography-Mass Spectrometry
9%
Relative Risk
9%
Trimethylamine N-Oxide
100%
Ultra-Performance Liquid Chromatography
9%
Biochemistry, Genetics and Molecular Biology
Blood Plasma
100%
Cohort Study
9%
Impaired Glucose Tolerance
27%
Insulin Resistance
100%
Intestine Flora
9%
Liquid Chromatography-Mass Spectrometry
9%
Prevalence
18%
Trimethylamine N-Oxide
100%